mitoxantrone has been researched along with Leukemia, Myelomonocytic, Chronic in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, JM | 1 |
| Young, MS | 1 |
| Liesveld, JL | 1 |
| Paietta, E | 1 |
| Miller, KB | 1 |
| Lazarus, HM | 1 |
| Marsh, RD | 1 |
| Friedenberg, WR | 1 |
| Saba, HT | 1 |
| Hayes, FA | 1 |
| Dewald, GW | 1 |
| Hiddemann, W | 1 |
| Rowe, JM | 1 |
| Brito-Babapulle, F | 1 |
| Barbatis, C | 1 |
| Whitmore, DN | 1 |
1 trial available for mitoxantrone and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Bon | 2001 |
1 other study available for mitoxantrone and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Laryngeal infiltration in chronic myelomonocytic leukaemia.
Topics: Aged; Airway Obstruction; Dyspnea; Female; Granulocytes; Humans; Larynx; Leukemia, Myelomonocytic, C | 1989 |